Table of Contents:

1 Report Prologue
1.1 Introduction
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.4.1 Assumptions
1.4.2 Limitations
2 Research Methodology
2.1.1 Primary Research Methodology
2.1.2 Secondary Research Methodology
2.1.3 Market Share Analysis
2.1.4 Market Pricing Approach
3 Market Dynamics
3.1 Introduction
3.2 Drivers
3.2.1 Increasing prevalence of neurovascular diseases like brain aneurysm, arteriovenous malformations (AVMs), and others, will propel the neurovascular devices market
3.2.2 Favourable reimbursement policies provide favorable background for market growth
3.2.3 Rising demands for minimally invasive therapeutic procedures and growing geriatric population will drive the neurovascular devices market growth
3.2.4 Ongoing product development & commercialization will boost the neurovascular devices market
3.3 Restraints
3.3.1 High procedural cost by neurovascular devices
3.3.2 Cases of injury and need for physician training
3.4 Opportunity
3.5 Mega trend
3.5.1.1 Increasing use of endovascular embolization for the treatment of brain aneurysm
3.6 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Value Chain Analysis
4.1.1 R&D and Designing
4.1.2 Manufacturing
4.1.3 Distribution & Sales
4.1.4 Post-Sales Review
4.2 Porter's Five Forces Model
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Threat of Substitutes
4.2.5 Intensity of Rivalry
4.3 Investment Opportunities
4.4 Pricing Analysis
4.5 Demand & Supply: Gap Analysis
5 Global Neurovascular Devices Market, By Product
5.1 Introduction
5.1.1 Aneurysm Coiling & Embolization Devices
5.1.1.1 Embolic Coils
5.1.1.1.1 Detachable Coils
5.1.1.1.2 Pushable Coils
5.1.1.2 Flow Diversion Devices
5.1.1.3 Liquid Embolic
5.1.2 Neurothrombectomy Devices
5.1.2.1 Retrieval Systems
5.1.2.2 Suction and Aspiration Devices
5.1.3 Support Device
5.1.3.1 Microcatheters
5.1.3.2 Microguidewires
5.1.4 Cerebral Balloon Angioplasty and Stenting Systems
5.1.4.1 Carotid Artery Stents
5.1.4.2 Embolic Protection Systems
5.1.4.2.1 Balloon Occlusion Devices
5.1.4.2.2 Distal Filter Devices
6 Global Neurovascular Devices Market, By Therapeutic Application
6.1 Introduction
6.1.1 Hemorrhagic stroke
6.1.2 Ischemic Strokes
7 Global Neurovascular Devices Market, By End User
7.1 Introduction
7.1.1 Hospitals & Clinics
7.1.2 Ambulatory Surgical Units
8 Global Neurovascular Devices Market, By Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 U.S.
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 U.K
8.3.1.4 Italy
8.3.1.5 Spain
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Republic of Korea
8.4.6 Rest of Asia Pacific
8.5 Middle East & Africa
8.5.1 United Arab Emirates
8.5.2 Saudi Arabia
8.5.3 Oman
8.5.4 Kuwait
8.5.5 Qatar
8.5.6 Rest of Middle East & Africa
9 Company Landscape
9.1 Company Share Analysis
10 Company Profiles
10.1 Stryker
10.1.1 Company Overview
10.1.2 Financials
10.1.3 Products
10.1.4 Strategy
10.1.5 Key Developments
10.2 Medtronic
10.2.1 Company Overview
10.2.2 Financials
10.2.3 Products
10.2.4 Strategy
10.2.5 Key Developments
10.3 Johnson & Johnson Services, Inc
10.3.1 Company Overview
10.3.2 Financials
10.3.3 Products
10.3.4 Strategy
10.3.5 Key Developments
10.4 TERUMO CORPORATION
10.4.1 Company Overview
10.4.2 Financials
10.4.3 Products
10.4.4 Strategy
10.4.5 Key Developments
10.5 Abbott
10.5.1 Company Overview
10.5.2 Financials
10.5.3 Products
10.5.4 Strategy
10.5.5 Key Developments
10.6 Merit Medical Systems, Inc.
10.6.1 Company Overview
10.6.2 Financials
10.6.3 Products
10.6.4 Strategy
10.6.5 Key Developments
10.7 Medikit co., ltd.
10.7.1 Company Overview
10.7.2 Financials
10.7.3 Products
10.7.4 Strategy
10.7.5 Key Developments
10.8 Penumbra, Inc.
10.8.1 Company Overview
10.8.2 Financials
10.8.3 Products
10.8.4 Strategy
10.8.5 Key Developments
10.9 MicroPort Scientific Corporatio
10.9.1 Company Overview
10.9.2 Financials
10.9.3 Products
10.9.4 Strategy
10.9.5 Key Developments
10.1 Evasc
10.10.1 Company Overview
10.10.2 Financials
10.10.3 Products
10.10.4 Strategy
10.10.5 Key Developments
10.11 Rapid Medical
10.11.1 Company Overview
10.11.2 Financials
10.11.3 Products
10.11.4 Strategy
10.11.5 Key Developments
11 Conclusion
11.1 Key Findings
11.1.1 CEO's Viewpoint
11.1.2 Key Companies to Watch
11.1.3 Prediction of NEUROVASCULAR Devices Industry
12 Appendix
12.1 Discussion Blue Print
12.2 References